MedPath
FDA Approval

pentobarbital sodium

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Sagent Pharmaceuticals
DUNS: 796852890
Effective Date
June 30, 2017
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Pentobarbital(50 mg in 1 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

pentobarbital sodium

Product Details

NDC Product Code
25021-676
Application Number
ANDA206404
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS, INTRAMUSCULAR
Effective Date
April 18, 2017
waterInactive
Code: 059QF0KO0RClass: IACT
Code: NJJ0475N0SClass: ACTIBQuantity: 50 mg in 1 mL
propylene glycolInactive
Code: 6DC9Q167V3Class: IACT
alcoholInactive
Code: 3K9958V90MClass: IACT
sodium hydroxideInactive
Code: 55X04QC32IClass: IACT
hydrochloric acidInactive
Code: QTT17582CBClass: IACT

Drug Labeling Information

Complete FDA-approved labeling information including indications, dosage, warnings, contraindications, and other essential prescribing details.

SPL UNCLASSIFIED SECTION

CII
SAGENT®
Rx only


© Copyright 2025. All Rights Reserved by MedPath